Kelly D. Sullivan
- Molecular Biology top 5%
- Oncology top 5%
- Cancer Research top 5%
- Public Health, Environmental and Occupational Health top 5%
- Immunology top 10%
- Co-authors
- Joaquı́n M. EspinosaMatthew D. GalbraithZdeněk AndrysíkWilliam F. MarzluffAhwan PandeyKeith P. SmithEric J. WagnerAnna L. Guarnieri
- Topics
- Cancer-related Molecular Pathways (11 papers)Down syndrome and intellectual disability research (8 papers)Epigenetics and DNA Methylation (8 papers)
- Partner nations
- United StatesItalyAustralia
In The Last Decade
Kelly D. Sullivan
48 papers receiving 2.5k citations
Peers
Comparison fields: 5 of 122
- Molecular Biology 1.6k
- Oncology 613
- Cancer Research 372
- Public Health, Environmental and Occupational Health 303
- Immunology 282
Countries citing papers authored by Kelly D. Sullivan
This map shows the geographic impact of Kelly D. Sullivan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kelly D. Sullivan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kelly D. Sullivan more than expected).
Fields of papers citing papers by Kelly D. Sullivan
This network shows the impact of papers produced by Kelly D. Sullivan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kelly D. Sullivan. The network helps show where Kelly D. Sullivan may publish in the future.
Co-authorship network of co-authors of Kelly D. Sullivan
This figure shows the co-authorship network connecting the top 25 collaborators of Kelly D. Sullivan. A scholar is included among the top collaborators of Kelly D. Sullivan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kelly D. Sullivan. Kelly D. Sullivan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 9 | |
| 3 | 2 | |
| 4 | 8 | |
| 5 | 26 | |
| 6 | 18 | |
| 7 | 13 | |
| 8 | 2 | |
| 9 | 31 | |
| 10 | 1 | |
| 11 | 34 | |
| 12 | 108 | |
| 13 | 126 | |
| 14 | 34 | |
| 15 | 39 | |
| 16 | 32 | |
| 17 | 21 | |
| 18 | 41 | |
| 19 | 81 | |
| 20 | 100 |
About Kelly D. Sullivan
Kelly D. Sullivan is a scholar working on Aging, Molecular Biology and Oncology, having authored 49 papers that have together received 2.5k indexed citations. Recurring topics across this work include Cancer-related Molecular Pathways (11 papers), Down syndrome and intellectual disability research (8 papers) and Epigenetics and DNA Methylation (8 papers). The work is most often cited by research in Cancer Research (372 citations), Molecular Biology (1.6k citations) and Oncology (613 citations). Kelly D. Sullivan has collaborated with scholars based in United States, Italy and Australia. Frequent co-authors include Joaquı́n M. Espinosa, Matthew D. Galbraith, Zdeněk Andrysík, William F. Marzluff, Ahwan Pandey, Keith P. Smith, Eric J. Wagner, Anna L. Guarnieri, Amanda A. Hill and James DeGregori. Their work appears in journals such as Cell, Proceedings of the National Academy of Sciences and Journal of Biological Chemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.